Status:
COMPLETED
A Quality Initiative to Improve Glycemic Control in Diabetic and Non-Diabetic Insulin Study
Lead Sponsor:
University of Vermont Medical Center
Conditions:
Glycemic Control
Surgical Site Infections
Eligibility:
All Genders
18-99 years
Brief Summary
The aim of this study is to examine the effect of moderate glucose (blood sugar) control in diabetic and non-diabetic patients undergoing leg bypass surgery (LEB) or open abdominal aortic aneurysm (AA...
Detailed Description
We plan a concurrent, matched cohort study of moderate postoperative glucose control in patients undergoing leg bypass or open AAA repair. Consecutive patients undergoing elective open AAA repair or l...
Eligibility Criteria
Inclusion
- Consecutive patients, all patients on the vascular service undergoing elective open AAA repair or infrainguinal LEB for claudication or critical limb ischemia will be approached and given the choice to participate in or to decline the study. Diabetic and non-diabetic.
Exclusion
- Patients with purely acute limb ischemia will be excluded. Emergency operations including ruptured AAA repairs will be excluded. Also patients on a preoperative insulin infusion will be excluded.
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT01916733
Start Date
January 1 2013
End Date
June 1 2016
Last Update
October 25 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fletcher Allen Health Care
Burlington, Vermont, United States, 05401